Rallis India Reports Lower Q2 FY27 Profit as Revenue Remains Flat
23 October 2026, Mumbai: Rallis India Limited reported revenue of ₹858 crore for the second quarter of FY27, compared with ₹861 crore in the corresponding quarter of the previous financial year, as weather-related disruptions and delayed sowing affected market demand.
Profit after tax (PAT) declined to ₹85 crore from ₹102 crore in Q2 FY26, while earnings before interest, taxes, depreciation and amortisation (EBITDA) fell to ₹126 crore from ₹154 crore. The company recorded an EBITDA margin of 14.7% and a PAT margin of 9.9% during the quarter.
For the first half of FY27, revenue increased to ₹1,880 crore from ₹1,818 crore in H1 FY26, representing growth of approximately 3%. PAT rose to ₹210 crore from ₹197 crore, an increase of around 6%, while EBITDA increased to ₹311 crore from ₹304 crore. The EBITDA margin stood at 16.5%, and the PAT margin was 11.2%.
Crop Care and Soil Health Businesses Record Growth
Rallis India’s Crop Care business recorded 4% growth in the second quarter, primarily driven by a 17% increase in the business-to-business (B2B) segment, supported by a recovery in its custom synthesis and manufacturing (CSM) portfolio.
(function() { var grid = document.getElementById(‘hln-grid’); if (!grid) return; fetch(‘https://www.global-agriculture.com/wp-json/wp/v2/posts?per_page=4&_fields=title,link,date’) .then(function(res) { return res.json(); }) .then(function(posts) { if (!Array.isArray(posts) || posts.length === 0) { grid.innerHTML = ”; return; } grid.innerHTML = posts.map(function(p) { var d = new Date(p.date); var dateStr = d.toLocaleDateString(‘en-GB’, { day: ‘numeric’, month: ‘short’ }); var title = p.title && p.title.rendered ? p.title.rendered : ”; return ‘
‘; }).join(”); }) .catch(function() { grid.innerHTML = ”; }); })();
Domestic Formulations (B2C) remained flat year-on-year. Within this segment, herbicides recorded 16% growth, while insecticides registered flat growth.
The Soil and Plant Health (SPH) business grew 22%, primarily driven by price growth, according to the company.
During the quarter, Rallis launched four products in its Crop Care portfolio: Silentra insecticide, Marcellus fungicide, Blitox Super fungicide and Trynage herbicide. The products target crop protection requirements including rice brown planthopper (BPH), sheath blight, sugarcane weed management and disease control in key horticultural crops.
Rallis India: Business Performance in Q2 FY27
| Business segment | Performance | Key driver |
|---|---|---|
| Crop Care | 4% growth | 17% growth in B2B, supported by recovery in the CSM portfolio |
| Domestic Formulations (B2C) | Flat year-on-year | Herbicides grew 16%; insecticides remained flat |
| Soil and Plant Health (SPH) | 22% growth | Price growth |
| Seeds | Decline | Higher returns from the kharif season |
Seeds Business Faces Seasonal Pressure
The Seeds business recorded a decline during the quarter, primarily due to higher returns from the kharif season, the company said.
Rallis Managing Director and CEO Gyanendra Shukla said weather-related disruptions and delayed sowing continued to affect market demand during the quarter and season.
The company said it would focus on improving market execution, driving cost efficiencies and strengthening customer engagement to address the operating challenges and improve business performance.
Also Read: Super Typhoon Champi, 2026’s Strongest Storm, Bears Down on Taiwan and East China
Global Agriculture is an independent international media platform covering agri-business, policy, technology, and sustainability. For editorial collaborations, thought leadership, and strategic communications, write to pr@global-agriculture.com
